Results 141 to 150 of about 5,211,707 (295)

Ranking Technologies of Additive Manufacturing of Removable Complete Dentures by the Results of Their Mechanical Testing. [PDF]

open access: yesDent J (Basel), 2023
Grachev DI   +9 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Ankle-foot orthosis mechanical testing: a scoping review. [PDF]

open access: yesJ Neuroeng Rehabil
Vaiciulis K, Williston Z, Totah D.
europepmc   +1 more source

Mechanical testing and comparison of porcine tissue, silicones and 3D-printed materials for cardiovascular phantoms. [PDF]

open access: yesFront Bioeng Biotechnol, 2023
Illi J   +7 more
europepmc   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Passive Mechanical Testing of Female Human Levator Ani and Superficial Perineal Muscles. [PDF]

open access: yesAnn Biomed Eng
Routzong MR   +5 more
europepmc   +1 more source

Hair-Reinforced Elastomer Matrix Composites: Formulation, Mechanical Testing, and Advanced Microstructural Characterization. [PDF]

open access: yesPolymers (Basel), 2023
Statnik ES   +5 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Mechanical Testing of Metal-Packaged FBG-Based Sensors Before and After High-Fluence Reactor Irradiation. [PDF]

open access: yesSensors (Basel)
Sapatayev Y   +8 more
europepmc   +1 more source

Mechanical Testing of Epoxy Resin Modified with Eco-Additives. [PDF]

open access: yesMaterials (Basel), 2023
Derewonko A, Fabianowski W, Siczek J.
europepmc   +1 more source

Home - About - Disclaimer - Privacy